Mayo Clinic home page [logo]

Search

  • Print
  • Share
close

Share this on...

Share this site with others using one of these sharing tools.

 

Link to this article

To link to this article, paste this block of HTML code onto your webpage.

Guidelines for sites linking to mayoclinic.org

Molecular Breast Imaging: A Better Way to Spot Tumors in Dense Tissue

Tuesday, March 10, 2009

ROCHESTER, Minn. — Molecular breast imaging (MBI), a new screening method for breast cancer, identifies tumors in dense tissue that often aren't visible with mammography. In the March issue of Mayo Clinic Women's HealthSource, Deborah Rhodes, M.D., a Mayo Clinic researcher who helped develop the technology, discusses why MBI may eventually serve as an adjunct to mammography.

MBI overcomes a shortcoming of mammography, which is taken with X-rays. The X-ray imagery doesn't differentiate between tumors and dense breast tissue. On a mammogram, they both appear white.

"With MBI, a tumor is easy to see, even if it's in dense breast tissue," says Dr. Rhodes.

Here's why: With MBI, a woman is given an injection of a short-lived radioactive agent. This material accumulates in tumor cells more than it does in normal cells. Using a radiation-detecting camera, tumors show up as hot spots on the resulting image.

In a recent Mayo Clinic study comparing MBI with mammography, MBI detected three times as many cancers in women with dense breast tissue and an increased risk of breast cancer. Another advantage over mammography: MBI also demonstrated fewer false positives, meaning the results appear abnormal but are noncancerous.

For now, MBI use is limited to research. The focus is to reduce the dose of radiation needed to perform MBI. The risk from the radiation dose of one or two MBI scans is extremely low. But to safely use MBI annually or every few years, the radiation dose needs to be reduced.

"Our goal is to have a dose that's no higher than that from a routine mammogram," says Dr. Rhodes. "If we get results that are similar to, or better than, our last study, we'll be well on our way to supporting MBI as an option for women with dense breast tissue."

###

Mayo Clinic Women's HealthSource is published monthly to help women enjoy healthier, more productive lives. Revenue from subscriptions is used to support medical research at Mayo Clinic. To subscribe, please call toll free
1-800-876-8633, extension 9751, or visit the Mayo Clinic Bookstore.

###

About Mayo Clinic

Mayo Clinic is the first and largest integrated, not-for-profit group practice in the world. Doctors from every medical specialty work together to care for patients, joined by common systems and a philosophy of "the needs of the patient come first." More than 3,700 physicians, scientists and researchers and 50,100 allied health staff work at Mayo Clinic, which has sites in Rochester, Minn; Jacksonville, Fla; and Scottsdale/Phoenix, Ariz. and community based providers in more than 70 locations in Southern Minn., Western Wis. and Northeast Iowa. These locations treat more than half a million people each year. To obtain the latest news releases from Mayo Clinic, go to www.mayoclinic.org/news. For information about research and education, visit www.mayo.edu. MayoClinic.com is available as a resource for your health stories.

Contact Information

For more information, contact:

Jesse Bradley

Ginger Plumbo
507-284-5005 (days)
507-284-2511 (evenings)
newsbureau@mayo.edu

Patient & Visitor Guide

Learn more about becoming a patient at Mayo Clinic in the Patient & Visitor Guide.

Terms of Use and Information Applicable to this Site
Copyright ©2001-2009 Mayo Foundation for Medical Education and Research. All Rights Reserved.

.